ROPEGINTERFERON ALFA-2B

FDA Drug Profile — BESREMi

Drug Details

Generic Name
ROPEGINTERFERON ALFA-2B
Brand Names
BESREMi
Application Number
BLA761166
Sponsor
PharmaEssentia USA
NDC Codes
1
Dosage Forms
INJECTION
Routes
SUBCUTANEOUS
Active Ingredients
ROPEGINTERFERON ALFA-2B

Indications and Usage

1 INDICATIONS AND USAGE BESREMi is indicated for the treatment of adults with polycythemia vera. BESREMi is an interferon alfa-2b indicated for the treatment of adults with polycythemia vera ( 1 )